Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over. - Pitiyarachchi, Omali; Ansell, Peter J.; Coleman, Robert L.; Dinh, Minh H.; Holman, Laura; Leath III, Charles A.; Werner, Theresa; DiSilvestro, Paul; Morgan, Mark; Tew, William; Lee, Christine; Cunningham, Mary; et al. (Gynecologic Oncology, 2024)